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Background: Vancomycin-resistant enterococci are pathogenic bacteria that 
have altered cell-wall peptidoglycan termini (D-alanyl-D-lactate [D-Ala-D-lactate] 
instead of D-alanyl-D-alanine [D-Ala-D-Ala]), which results in a 1 OOO-fold 
decreased affinity for binding vancomycin. The metallodipeptidase VanX 
(EntVanX) is a key enzyme in antibiotic resistance as it reduces the cellular pool 
of the D-Ala-D-Ala dipeptide. 
Results: A bacterial genome search revealed vanX homologs in Streptomyces 
toyocaensis (StoVanX), Escherichia co/i (EcoVanX), and Synechocystis sp. 
strain PCC6803 (SynVanX). Here, the D,D-dipeptidase catalytic activity of all 
three VanX homologs is validated, and the catalytic efficiencies and 
diastereoselectivity ratios for dipeptide cleavage are reported. The ecovanX 
gene is shown to have an RpoS (@)-dependent promoter typical of genes 
turned on in stationary phase. Expression of ecovanxand an associated cluster 
of dipeptide permease genes permitted growth of E. co/i using D-Ala-D-Ala as 
the sole carbon source. 
Conclusions: The key residues of the EntVanX active site are strongly 
conserved in the VanX homologs, suggesting their active-site topologies are 
similar. StoVanX is a highly efficient D-Ala-D-Ala dipeptidase; its gene is located 
in a VanHAXoperon, consistent with a vancomycin-immunity function. StoVanX 
is a potential source for the VanX found in gram-positive enterococci. The 
catalytic efficiencies of D-Ala-D-Ala hydrolysis for EcoVanX and SynVanX are 
25-fold lower than for EntVanX, suggesting they have a role in cell-wall 
turnover. Clustered with the ecovanXgene is a putative dipeptide permease 
system that imports D-Ala-D-Ala into the cell. The combined action of EcoVanX 
and the permease could permit the use of D-Ala-D-Ala as a bacterial energy 
source under starvation conditions. 
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Introduction 
Vancomycin-resistant enterococci (VRE) have become 
recognized as important opportunistic human pathogens 
over the past decade. As vancomycin has become a front- 
line drug for the treatment of enterococcal infections, as 
well as those caused by methicillin-resistant Sfa@ylococ- 
cus aurezls (MRSA), resistance and mortality from VRE 
has increased and an infectious catastrophe for MRSA is 
looming [l-4]. The most prevalent clinical phenotypes 
of vancomycin resistance, VanA and VanB [S], require 
expression of the genes vanR, vans, vanH, vanA, and 
vanX (VanA phenotypic nomenclature) [6] to produce 
peptidoglycan chain precursors with altered termini for 
cell-wall biosynthesis that exhibit dramatically lower 
affinity for vancomycin. Vans and VanR act as a two-com- 
ponent regulatory system to mediate antibiotic-induced 
transcription of the genes vanH, vanA, and vanX, whose 
products act sequentially (VanH, VanA) to synthesize the 
depsipeptide D-alanyl-D-lactate (D-Ala-D-lactate), in 
place of the normal D-alanyl-D-alanine (D-Ala-D-Ala) 
dipeptide. VanX is a zinc-containing D,D-dipeptidase that 
hydrolyzes D-Ala-D-Ala but not D-Ala-D-lactate, allow- 
ing the D,D-depsipeptide to accumulate and become 
incorporated into the growing peptidoglycan termini. The 
modified peptidoglycan binds vancomycin lOOO-fold less 
avidly than the D-Ala-D-Ala peptidoglycan [7,8] and 
results in unimpeded peptide-strand cross-linkng, yield- 
ing a mechanically strong cell wall and resistance to lysis 
and cell death in the presence of vancomycin. 
There is substantial interest in deciphering the mecha- 
nism, substrate selectivity and three-dimensional structure 
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(a) Sequence alignment of the VanX homologs. EntVanXA, 
Enterococcus faecium VanX; EntVanXB, E. faecahs VanX; StoVanX, 
Sfrepfomyces toyocaensis VanX homolog; EcoVanX, Escherichia co/i 
VanX homolog; SynVanX, Synechocysfis sp. PCC6803 VanX 
homolog. Identity and similarity are denoted by light gray background. 
The zinc ligands (orange), the catalytic base and transition-state 
residues (red), the substrate binding residues (blue) and the auxiliary 
residues involved in maintaining the active-site architecture (purple) are 
denoted by color boxes. The key portions of secondary structure of 
EntVanX, (CL helices, 8 strands and 3,, helices) are denoted by their 
respective abbreviations; CI, p and H. (b) Phylogenetic relationship 
among VanX homologs as calculated using the Clustal W method 
1521. The branch length (numerical values in arbitrary units) is a 
measure of sequence divergence and is assumed to be approximately 
proportional to the phylogenetic distance. The phylogenetic tree was 
derived using the TREE program of Feng and Doolittle [59]. 
of VanX, given that metalloproteases operating in other 
biological contexts (e.g. angiotensin-converting enzyme) 
have been inhibited by rationally designed therapeut- 
ic agents (such as the angiotensin-converting-enzyme 
inhibitors). Among the relevant issues for investigation is 
the likely origin of the transposon-encoded vanX in VRE 
and its distribution in other bacteria, both gram-positive 
and gram-negative. We have recently reported a mutage- 
nesis study on the Enterococcus faecium VanX (the Ent- 
VanXA from the VanA VRE phenotype), identifying 
putative enzyme ligands for zinc coordination and for 
general base catalysis of the attacking water molecule 
[9]. Crystallographic determination of the structure of 
EntVanX* has confirmed the conclusions of this study 
and revealed the enzyme architecture, including details 
of the active-site topology [lo]. 
We have used the key residues in the zinc-binding motif of 
EntVanX* as a signature sequence to search for VanX 
homologs in bacterial genome databases to detect a VanX 
homolog from the glycopeptide-producer bacterial genome 
Streptomyces toyocaensis [ll] and have found VanX type 
open reading frames (ORFs) in both gram-positive bacteria 
(3. toyocaensis [StoVanX], 64% similarity with EntVanXJ 
and, with much lower homology, in gram-negative bacteria 
(Eschetichia coli [EcoVanX], 27% similarity; Synechocystis p. 
strain PCC6803 [SynVanX], 16% similarity). We report 
here the purification and validation of enzymatic zinc- 
dependent D,D-dipeptidase activity of these three bacter- 
ial VanX homologs. Furthermore, we have analyzed the 
potential functions of EcoVanX and five downstream 
genes for catabolic function, induced during stationary 
phase by the @ factor of E. co/i RNA polymerase. 
Results 
Residues that predict zinc-dependent D,D-dipeptidase 
activity 
In an earlier study of the zinc-dependent metallodipepti- 
dase EntVanX, required for clinically significant vanco- 
mycin resistance, we identified, using site-directed muta- 
genesis, residues Hisllb, Asp123 and His184 as likely 
ligands for zinc coordination and Glu181 as the probable 
general base for deprotonation of the zinc-coordinated 
water molecule that subsequently attacks the D-Ala-D-Ala 
substrate 191. The recent crystallographic structure deter- 
mination of EntVanX* has borne out these assignments 
[lo] and has led us to search for homologs of VanX in 
other bacterial genomes to gain insight into the structural 
and functional origins of the transposon-borne EntVanX. 
As illustrated in Figure la, the zinc ligand and general 
base residues are conserved in the similarly sized StoVanX 
(208 amino acids [aa]), EcoVanX (193 aa) and SynVanX 
(247 aa) ORFs, suggesting that they are bonafide members 
of the zinc-protease VanX family, even though the low 
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Overproduction and purification of MBP-VanX fusion proteins. f. co/i 
BL21 (DE3) cells were transformed with plADL14/plADL55/plADL58 
or plADL61, grown, and induced with IPTG as described in the 
Materials and methods section. Each recombinant MBP-VanX fusion 
protein was purified on an amylose column. Protein samples were 
analyzed for purity using SDS-PAGE with Coomassie Blue staining. 
Lane 1, molecular weight markers (phosphorylase B, 97.4 kDa; serum 
albumin, 66.2 kDa; ovalbumin, 45.0 kDa; carbonic anhydrase, 
31 .O kDa; trypsin inhibitor, 21.5 kDa; lysozyme, 14.4 kDa); lane 2, 
E. co/i cells transformed with plADLl4 (before induction); lanes 3, 5, 7 
and 9, clarified lysate of induced cells transformed with plADLl4, 
plADL61, plADL55 and plADL58 respectively; lanes 4, 6, 8 and IO, 
MBP fusion protein eluted from the amylose column (MBP-EntVanX, 
MBP-StoVanX, MBP-EcoVanX and MBP-SynVanX, respectively). 
sequence similarity of 27% for EcoVanX and 16% for 
SynVanX might have otherwise been below detection 
limits (Figure lb). To overproduce the three VanX 
homologs in Escherichia coli, the affinity purification strat- 
egy used for EntVanX* (202 aa) involving in-frame fusions 
to maltose-binding protein (MBP) was adapted, and led ‘to 
single-step purification of each of the three EntVanXA 
homologs (Figure 2). Zinc analysis revealed that all the 
VanX homologs did contain the metal ion, although the 
SynVanX protein contained only 55 mol% zinc (Table 1). 
We have not attempted additional quantitation of the zinc 
content of SynVanX, but have used the result as a valida- 
tion of the anticipated zinc-dependent dipeptidase activ- 
ity of this enzyme. In keeping with this prediction, and as 
observed with EntVanX* [9], all the VanX homologs 
retained activity as D,D-dipeptidases when fused to MBP. 
Thus, the kinetic data reported in Table 1 were obtained 
using the intact MBP-fusion protein in each case. 
Catalytic properties of VanX homologs 
Table 1 reveals a one log variation in K,,, for D-Ala-D-Ala 
hydrolysis by the various VanX homologs (12 s-l for 
StoVanX; 310 s-l for SynVanX). The variation in KM 
values was much larger (4 pM for StoVanX, 14 mM and 
16 mM for EcoVanX and SynVanX respectively). Corre- 
spondingly, the catalytic efficiency (R,,,/K,) of StoVanX 
Kinetic parameters and zinc content of purified MBP-VanX 
fusion proteins. 
kC.dKM mol O/a Zn 
Substrate Protein kc&-') K&M) (s-l mM-l) content 
o-Ala-o-Ala EntVanX 26 80 325 95 
StoVanX 12 4.0 3000 84 
EcoVanX 170 1.4x103 12 100 
SynVanX 310 1.6~10~ 19 55 
L-Ala-o-Ala EntVanX 1.2 30x103 0.04 
StoVanX 10 6.8x103 1.5 
EcoVanX 70 >55ox 103 0.13 
SynVanX 110 8.3~10~ 13 
(3,000 rnM-‘s-l) is tenfold better than that of EntVanX, 
(325 mM-ls-‘) and 1.50- and GO-fold higher than that of 
SynVanX and EcoVanX, respectively. 
The 4,000-fold variation in KM values for D-Ala-D-Ala 
observed in the VanX homologs prompted a search for 
alternate substrates of these enzymes, especially for 
EcoVanX and SynVanX, which have high KM values. No 
dipeptidase activity was detected with L-Ala-L-Ala or 
D-Ala-L-Ala for any of the four enzymes, but the hetero- 
chiral dipeptide L-Ala-D-Ala was accepted as substrate 
(see below; Table 2). As observed with EntVanX, [12], 
both the N”-amino group and the carboxylate moiety of 
the dipeptide substrate had to be free as evidenced by the 
absence of peptidase activity towards N-acetyl-D-Ala- 
D-Ala and D-Ala-D-Ala-O-methyl ester (Table 2). Dis- 
crimination between the peptide-bond cleavage (D-Ala- 
D-Ala) and the analogous ester-bond cleavage (D-Ala- 
D-lactate) reported for EntVanXA, is also observed for all 
three VanX homologs (Table 2). 
The L-Ala-D-Ala hydrolase activity data for the VanX 
homologs are summarized in Table 1. The R,,, values for 
turnover were respectable, ranging from 1.2 s-l (Ent- 
VanX*) to 110 s-l (SynVanX). The KM values for the 
L,D-dipeptide are generally much higher that those for 
the cognate D,D-substrate. For example, StoVanX recog- 
nizes L-Ala-D-Ala with a KM of 6.8 mM, which is 1,700- 
fold worse than its affinity for D-Ala-D-Ala (KM of 4 pM). 
Similarly, EntVanX* recognizes the L,D-dipeptide 400- 
fold worse than the D,D-dipeptide substrates. Because 
EcoVanX activity was not saturated, even at 300 mM 
L,D-dipeptide, a KM greater than 550 mM is estimated 
for this substrate. In sharp contrast, SynVanX has a 
twofold lower KM for the L,D-dipeptide (8.3 mM) versus 
the D,D-dipeptide (16 mM). The ratios of catalytic effi- 
ciency (k,,,/K, ) for L-Ala-D-Ala and D-Ala-D-Ala are 
lo-?1 to lOA:1 for EntVanX, and StoVanX, respectively, 
and emphasize this discrimination. EcoVanX shows a 
lo-?1 ratio, whereas SynVanX is clearly indifferent to 
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Table 2 
Substrate specificity of the various VanX homologs as 
dipeptidases and oligopeptidases. 
Substrate EntVanX StoVanX EcoVanX SynVanX 
D-Ala-D-Ala + + + + 
D-Ala-L-Ala 
L-Ala-D-Ala + + + + 
L-Ala-L-Ala 
Aib-D-Ala* + + + + 
L-Ala-DGIuNH, 
D-Ala-D-Ala-CMe 
NAc-D-Ala-D-Ala 
D-Ala-D-Ala-D-Ala . - 
L-Ala-L-Ala-L-Ala 
D-Ala-D-lactate 
D-Ala-y-D-Glu-L-Lys- - - 
D-Ala-D-Ala 
Each substrate (10 mM) was incubated with 2-4 uM enzyme and the 
activity was determined visually by the Cd-ninhydrin assay (see the 
Materials and methods section). *Aminoisobutyryl-D-Ala. 
the chirality of the first alanine residue, with a ratio of 
0.7:1. This last result predicted that SynVanX should 
process the dipeptide aminoisobutyryl-D-Ala efficiently, 
consistent with its ability to accommodate the methyl 
sidechain of both D-Ala and L-Ala. Only a low dipeptidase 
activity could be detected with this substrate, however, 
indicating that either structurally hindered molecules 
were not tolerated or that conformational constraints of 
the a,a-dialkyl residue prevented hydrolysis of the 
peptide bond (data not shown). 
Sequence and structural homology of VanX homologs with 
EntVanX, 
The recent crystallographic determination of the structure 
of EntVanX* protein has revealed several key residues 
involved in binding\and cleavage of the D-Ala-D-Ala sub- 
strate, and in maintaining the active-site structure [lo]. 
These residues can be categorized as follows: zinc ligands 
(Hisllb, Asp123 and His184), catalytic residues (Glu181 
and Arg71), substrate-binding residues (Tyr21, Asp123, 
Asp142, Serll4 and Serll.5), and auxiliary residues at the 
active site (Tyr35, Asp68, Pro72, Serll7, Trpl82 and 
Trp183). As illustrated in Figure la, despite the low per- 
centage of overall sequence similarity between EntVanX, 
and EcoVanX (27%) or SynVanX (16%), the key active- 
site residues are conserved, which implies, together with 
the dipeptidase activity, that these enzymes use similar 
mechanisms for proteolysis and substrate binding, and 
confirms a functional role for these homologs as zinc- 
dependent D,D-dipeptidases. 
For all VanX homologs, the three residues involved in zinc 
coordination (Hisll6, Asp123 and His184) are conserved, 
consistent with the presence of zinc in the purified 
enzymes (Table 1). In EntVanX*, the nucleophilicity of a 
water molecule, the fourth zinc ligand, is enhanced by 
hydrogen bonding to Glu181, which acts as a general base. 
Attack of the scissile peptide bond by this activated water 
molecule generates a tetrahedral adduct that is believed 
to be stabilized by Arg71. This mechanism of catalysis 
appears to operate in all the VanX homologs, as both 
Glu181 and Arg71 are conserved in each system. 
The active site of EntVanX* is capable of accommodating 
only a dipeptide as a substrate because it is compact and 
consists of a narrow channel lined at the distal end with 
residues (Tyr’21, Asp123 and Asp142) that make key 
hydrogen bonds with the W-amino group of the substrate. 
This cluster of residues is generally conserved in the 
VanX homologs, although a serine residue (which can still 
participate in hydrogen bonding) replaces Tyr21 of Ent- 
VanXA in SynVanX. Such an active-site topology empha- 
sizes the prerequisite for a free primary amino group in the 
substrate and would explain the absence of activity 
towards protected-amino-group substrates for all VanX 
homologs (Table 2). A significant diversity in residue 
identity is observed at positions corresponding to Serl14 
and Serl15 in EntVanXA believed to be involved in 
binding of the carboxylate group of the D-Ala-D-Ala sub- 
strate [lo]. Serll4 is conserved in two homologs but a 
proline residue is found at this position in SynVanX. 
Serl15 is absent in all homologs, including the tenfold 
more efficient enzyme StoVanX. Substitution of Serll5 
with bulkier residues (asparagine in EcoVanX and proline 
in SynVanX) could account for the higher KM values for 
D-Ala-D-Ala observed in these systems. 
Striking similarities are found in the auxiliary residues 
that maintain the active-site topology in the VanX family 
of proteins. In EntVanX,, Asp68 is positioned to form 
hydrogen bonds with Tyr35 and the &-nitrogen of Arg71, 
which is believed to be important in ensuring the proper 
orientation of Arg71 in the active site. These residues, 
which comprise the hydrogen-bonding triads, are con- 
served in all VanX homologs. Similarly, Serll7 in Ent- 
VanXA hydrogen bonds with Pro7’2, which, in turn, 
hydrogen bonds to Hisllb, thereby assuring the proper 
orientation of His1 16. Again, these residues are conserved 
in all the VanX homologs. The conserved residues 
Trpl82 and Trp183 appear to be involved in enzyme sta- 
bility. Trp182 forms an aromatic network with several 
other aromatic sidechains, namely Trp67, Phel41 and 
Tydl. As is typical of such interactions, the aromatic 
groups lie in a herringbone pattern [13]. It should be 
noted that the aromatic character of these residues is 
highly conserved across the identified VanX homologs. 
There is also the possibility of Trp183 acting as a hydro- 
gen-bond acceptor for the amino-group of the first 
residue of the D-Ala-D-Ala substrate, as is shown in the 
co-crystal structure of EntVanX* with D-Ala-D-Ala [lo]. 
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The hydrogen-bond distance of 3.8 A suggests this is a 
weak bond (if it does exist). 
Three-dimensional homology modeling of EcoVanX 
The conservation of key active-site residues in the VanX 
homologs together with the modest overall sequence 
homology allowed homology modeling of the three- 
dimensional structure of a typical EntVanX homolog 
(EcoVanX, Figure la) using the crystal structure of Ent- 
VanXA as structural template. The alignment and model 
follow the rules of protein folding: residues are in suitable 
chemical and structural environments. Insertion and dele- 
tions within the E. coli homolog occur primarily outside 
elements of secondary structure with the exception of a 
small deletion in the a2 helix and the deletion of the 
entire a3 helix; the loop between the a4 and H3 helices is 
also absent. The resulting homology model superimposes 
with the crystal structure with an RMS deviation of 1.38 A 
over 176 a-carbons (Figure 3a). Major alterations are seen 
in the mainchain path at the carboxyl terminus where 
several small 2-3 residue insertions have occurred. 
Despite these modifications, the active site remains virtu- 
ally identical to that of EntVanXA (Figure 3b). The 
residues responsible for zinc coordination are present, rep- 
resented by His98, Aspl05, and His165. The key catalytic 
residues, Arg71 and Glu162, are also present, as are the 
residues responsible for interacting with the amino group 
of the substrate (Tyr23, Asp123, and Aspl05). Residues 
responsible for interacting with the carboxylate of the 
substrate (Ser96 and Asn97) are shifted inwards towards 0 
the active site by 2-3 A, this alteration is due to a deletion 
amino-terminal to this portion of the molecule. The 
repositioning of this loop might be one of the factors for 
the increased KM observed for D-Ala-D-Ala. Another con- 
tributor to the increased KM is most certainly the minor 
repositioning of key sidechains, which cannot be pre- 
dicted by the model. Aside from the noted differences, 
the differences between the crystal structure and the 
homology model are negligible. The structural and 
sequence conservation between VanX homologs suggests 
this to be a case of divergent evolution wherein all the 
homologs are derived from a common ancestor. This 
hypothesis is strengthened by the sequence comparison, 
where the most divergence is seen within loops and the 
highest identity is seen within key catalytic-residue posi- 
tions and domains of secondary structure. 
Possible physiological roles for EcoVanX 
Analysis of the gene organization at minute 33.7 of the 
E. coli chromosome (Figure 4), reveals that ecovanX is 
directly (13 basepairs [bp]) upstream of five ORFs with 
homology to oligopeptide and dipeptide permease genes. 
The latter genes also are organized in a fashion similar to 
other peptide permease clusters, and would be sufficient to 
code for a complete transport system with periplasmic and 
membrane components. Noteworthy is the or$A (f516) gene 
Figure 3 
&Biology 1 
Comparison of the EcoVanX structural homology model (red) with 
EntVanX, (blue). (a) Comparison of the a-carbon backbone. 
(b) Comparison of the key active-site residues (numbering, EntVanX, 
[EcoVanX]): zinc ligands (His1 16 [His98], His1 84 [His1 651 and 
Asp1 23 [Asp1 05]), catalytic residues (Glul81 [Glul62] and Arg71 
[Arg71]) and substrate binding (@-amino group; TyrPl [Tyr23] and 
Apsl42 [Asp1 231). The zinc ion is shown as a yellow sphere. 
(Figure 4), which codes for a homolog to the periplasmic 
dipeptide-binding protein DppA in E. coli (23% similarity) 
[14]. If D,D- (or L,D-) dipeptides are thereby imported, 
perhaps cytoplasmic EcoVanX catabolizes such dipeptide 
metabolites. Coexpression of ecovanx and the permease 
gene cluster is demonstrated below. 
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Figure 4 
Gene organization at 33.7 minutes of the 
E. co/i chromosome [45]. ecovanX, EcoVanX 
gene product (ORF-f193, accession 
1787763); orfA, gene coding for a homolog 
to the dipeptide-binding protein DppA from 
f. co/i (ORF-f516, accession 1787762); orfB, 
gene coding for a homolog to the dipeptide 
transport permease DppB from E. co/i (ORF- 
f340, accession 1787761); OK, gene 
coding for a homolog to the dipeptide 
transport permease DppC from E. co/i (ORF- 
f298, accession 1787760); orfLI, gene 
coding for a homolog to the oligopeptide 
transport ATP-binding protein OppD from 
Salmonella thyphimurium (ORF-f328, 
accession 1787759); orfF, gene coding for a 
homolog to the oligopeptide transport ATP- 
binding protein AppF from Bacillus subfillis 
(ORF-f308, accession 1787758); orfX, 
hypothetical protein gene product (ORF-f807, 
accession 1787765); osmC, gene for 
osmotically inducible protein. The noncoding 
sequence between the orfX gene and the 
ecovanX gene is shown. A putative 
transcriptional terminator for the orfxgene 
Hypothetical dipeptide permease gene cluster 
orfx ecovanX orfA orfB 0rfC orfD orfF osmC 
AGGCTGGATGAGCAGCGTGTTACCGCTGAAAATCTOACAA 
GWMSSVLPLKI* 
GGGTTTTCATTTAACGTGACACTGTCACTTAAATACTGTGATTTCA TCCGGGA 
GATTCCTTCCTTAACTTCCCCTCTTGCACC CGCTGCACAAATGTTGATC 
AAAAGTT AAAAAATATAACTTTAAGCCAGCATTCTGGCGCTTATCCCGGCATGGCATGAGA 
rbs 
TCTGCATAAGCGGAAAGCGCAGC~TTTTTGTCTTATACAGG~CCGT~TATGTCGGATAC 
M S D T 
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and the ribosome binding site (rbs) for the 
ecovanxgene is underlined. The putative oS 
-10 regions are indicated by orange boxes. 
The region used for a transcriptional fusion 
construct with /acZ (see Figure 5a) is 
indicated in bold. The red arrows indicate the 
sites of priming sites used for the RT-PCR 
(see Figure 5b). 
Upstream of the ecovanX gene are -260 bp of noncoding 
DNA with two putative -10 sequences for a @ (RpoS) regu- 
lated promoter (consensus: CTATACT [15]; Figure 4), sug- 
gesting that this cluster of genes is induced during 
stationary phase [16]. A -10 sequence for the 070-depen- 
dent promoter was also detected in this region; the puta- 
tive -35 promoter sequence is at a spacing so close that it 
would be placed on the opposite face of the DNA with 
respect to the -10 element, however. To test whether 
ecovanX is indeed regulated by the stationary phase 0s 
factor of E. coli RNA polymerase, we constructed a fusion 
of the proposed promoter with lad and integrated a single 
copy into the chromosome of E. colic strains BW22653 
@OS+) and BW24180 @OS-) to establish whether there was 
a dependence on @ (strains IALD310 and IADL313, 
respectively). Indeed, growth studies showed a tenfold 
induction of the P ~~Ouanx-lacZ fusion only in the strain carry- 
ing a functional rpoS gene (Figure 5a). Induction is acti- 
vated early during the transition into stationary phase as 
observed in other @-dependent genes (e.g., otsAB [17] and 
bolA [18]). The phenotype of @-dependent induction could 
be restored in the rpoS mutant strain by the presence of 
plasmid pDEB2 expressing the rpoS gene (data not shown). 
We have used reverse transcription polymerase chain reac- 
tion (RT-PCR) technology to determine if ecovanX and 
the dipeptide permease genes are coexpressed during sta- 
tionary phase. Although we were not able to find condi- 
tions for an RT-PCR product of the entire cluster 
(expected product of over 6,000 bp), we were able to RT- 
PCR amplify the region that includes the ecovanx gene 
and the first gene of the putative dipeptide permease 
cluster (or$A). (Figure 5b (i), Figure 4). In a separate reac- 
tion we also detected an RT-PCR product corresponding 
to the distal four genes (or$BCDF) of the dipeptide perme- 
ase cluster (Figure 5b (ii), Figure 4). Furthermore, both 
products showed a similar pattern of transcription, with 
the highest level during stationary phase, in agreement 
with the transcriptional fusion study of the PecOuanx with 
lacZ (see above and Figure 5a). These results show that 
the ecovanX and the dipeptide permease genes form a 
tight cluster that is induced during stationary phase. 
Growth of E. coli on D-Ala-D-Ala as carbon and energy 
source 
Initial attempts to detect growth of E. coli BWZ5113 on 
D-Ala-D-Ala were not successful although, E. coli has 
been reported to grow on D-Ala [19]. If sufficient 
EcoVanX were produced, one would expect growth by 
subsequent oxidation of the D-Ala by the membrane 
bound D-amino acid dehydrogenase (D-ADH), which 
passes electrons into the respiratory chain [ZO]. In the 
event that the level of expression of ecovanX was too low 
to sustain growth under laboratory conditions, we con- 
structed an E. col’i strain (IADL307) harboring a second 
copy of the ecovanX gene under the control of PihC to 
induce high level expression. In fact, this strain showed 
growth on D-Ala-D-Ala, whereas the parent strain 
(SW25 113), which has the resident ecovanX gene under its 
own promoter, did not sustain growth (Figure 6). The 
growth of strain IADL307 was also sustained in the 
absence of the inducer IPTG, suggesting that low levels 
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(a) Involvement of rpoS in a growth-phase-dependent induction of 
/acZ by the ecovanX promoter (see Figure 4). Expression of /acZ was 
determined in isogenic rpoS+ (red circles) and rpoS- (blue squares) 
strains. Stationary phase cultures were diluted (1 :lO) into LB medium 
and incubated at 37°C with agitation for 30 min. The dilution and 
incubation steps were repeated three times. The growth at 37°C was 
monitored by absorbance at 600 nm (green triangles, average of all 
cultures) and specific P-galactosidase activity (Miller units) was 
determined at various growth stages. These experiments were carried 
out in triplicate. (b) Analysis of the ecovanXand dipeptide permease 
transcripts. Total RNA was prepared from E. co/i NM522 cultures in 
exponential phase (lane 1) and stationary phase (lane 2) and was 
used to amplify the gene cluster by RT-PCR (see Figure 4) as 
described in the Materials and methods section. (i) shows the PCR 
product of the region from ecovanX to orfA (expected 1455 bp). (ii) 
shows the PCR product of the region from orf/3 to orfF (expected 
2248 bp). Identity of the PCR products was confirmed by restriction 
mapping (data not shown). 
of expression were sufficient (P,aC is repressed by LacIq 
present in these strains). 
Previously we observed that overproduction of EntVanX* 
under control of the T7 promoter in E. coGi led to rapid 
cell death and lysis [9], in contrast to the successful over- 
production of EcoVanX from the same promoter (this 
work). To assess whether cell death was due to the higher 
catalytic efficiency of EntVanX, as a D-Ala-D-Ala hydro- 
lase, an E. co/i strain (IADL318) harboring a single chro- 
mosomal copy of the entvanXA gene under P/,, control was 
made. Indeed this strain shows growth on D-Ala-D-Ala 
(data not shown), suggesting that there is a fine balance 
between sufficient dipeptidase activity to sustain growth, 
and so much enzyme that all intracellular D-Ala-D-Ala is 
hydrolyzed and cell-wall synthesis is halted. 
Discussion 
Of the five resistance proteins, VanR, Vans, VanA, VanH 
and VanX in VanA and VanB phenotypes of vancomycin- 
resistant enterococci (VRE), VanX was the only one for 
which homology searches did not initially reveal function 
by relationship to other known proteins [6,21-231. The 
first indication that VanX functions as a D,D-dipeptidase 
came from the work of Reynolds etal. [7]; it was only after 
detection of zinc in the purified EntVanXA enzyme [12] 
and subsequent identification of putative zinc-l&and 
residues by site-directed mutagenesis [9] that the connec- 
tion to the D,D-carboxypeptidases VanY [24,2.5], the Strep- 
tomy~es a&us G D-Ala-D-Ala carboxypeptidase [26] and to 
some phage-encoded endolysins [9] was discovered. The 
function of EntVanX is clearly to alter Fhe pools of cyto- 
plasmic D-Ala-D-lactate:D-Ala-D-Ala by selective hydro- 
lytic removal (lO’j:l) of the dipeptide [12], such that 
D-Ala-D-lactate is preferentially utilized in enterococcal 
cell-wall biosynthesis, yielding essentially all nascent pep- 
tidoglycan chains terminating in D-Ala-D-lactate, enabling 
vancomycin resistance. The basis of the million-fold pref- 
erence for D,D-dipeptide as substrate for VanX instead of 
D,D-depsipeptide is not yet understood in EntVanX or any 
of the VanX homologs. 
The recent detection of a vanHAX gene cluster in the 
glycopeptide-antibiotic-producing S. toyocaemis [ 111, and 
the demonstration herein that purified StoVanX possesses 
both the anticipated D-Ala-D-Ala dipeptidase activity and 
lacks D-Ala-D-lactate depsipeptidase activity is satisfying 
on several accounts. First, it suggests a clear and con- 
served mechanism for the observed intrinsic resistance of 
the antibiotic producers to the vancomycin class of gly- 
copeptides. Second, it suggests an obvious evolutionary 
source of the genes encoding VanHAX proteins (.540/o, 
63%, 64% homology, respectively, to the EntVanHAX 
counterpart in the VanA phenotype) in pathogenic VRE, 
by gene transfer from such antibiotic producers, and is con- 
sistent with the view that antibiotic resistance genes might 
have evolved at the same time as antibiotic biosynthesis 
genes. In S. toyocaensis there are two D-,D-ligases: a D-Ala- 
D-Ala ligase and a D-Ala-D-lactate ligase [27]; the latter 
could be switched on transcriptionally as the host com- 
mences antibiotic biosynthesis, allowing cell-wall termini 
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Growth of E. co/i on D-Ala-D-Ala or D-Ala as 
carbon source. A single colony of E. co/i 
grown on LB was used to streak an M9 
(Miller) media plate containing (a) 5 mM 
D-Ala-D-Ala or (b) 10 mM D-Ala as the sole 
carbon source at 37°C for 4 and 2 days, 
respectively (in the absence of IPTG). 1, E, 
co/i strain BW251 13; 2, E. co/i strain 
IADL319 (P,,,-dipepfide permease); 3, E. c 
strain IADL307 (P,aC-ecovanXJ; 4, E. co/i 
strain IADL321 (P,,,-dipeptide permease, 
f,,,-ecovanX). All E. co/i strains are 
described in the Materials and methods 
section. 
a 
o/i 
to be reprogrammed to create immunity to vancomycin in 
a timely fashion. Such a regulatory circuit has yet to be 
verified experimentally. 
It is highly likely that EntVanX and StoVanX serve analo- 
gous functions in the physiological destruction of D-Ala- 
D-Ala in the cytoplasm and the high R,,,IK, catalytic effi- 
ciency ratios of 3.25 x lo5 M-is-l and 3 x lo6 M-W for 
dipeptide hydrolysis are consistent with this prediction. In 
contrast, EcoVanX and SynVanX fall short in catalytic effi- 
ciency (ZO-fold less effective), with a ZOO-fold increase in 
K, values for D-Ala-D-Ala for these enzymes compared to 
EntVanX*. The relative inefficiency of these two VanX 
homologs in binding and hydrolysis of D,D-dipeptides 
tempered our initial surprise upon discovering these pro- 
teins in the cyanobacterium Synechoqstis and in particular 
in E. co/i. There is no comparable D-Ala-D-lactate pepti- 
doglycan alternative pathway for cell-wall biosynthesis in 
E. co/i and, as gram-negative organisms, Synechocystis and 
E. coli are never challenged by glycopeptide antibiotics of 
the vancomycin class (because the antibiotic cannot pene- 
trate the outer cell membrane). 
The above observations raised the prospect that the 
EcoVanX homolog, which clearly possesses zinc D,D-dipep- 
tidase activity, might operate on an alternate substrate, 
derived from the peptidoglycan layer (Figure 7). For 
example, one could imagine murein hydrolase roles for 
this enzyme. In this regard, D,D-endopeptidase, D,D-car- 
boxypeptidase, and L,D-carboxypeptidase activities have 
been previously described for E. colz [28,29]. The initial 
scan of potential peptidyl substrates (Table 2) rules 
against hydrolysis of N-acyl-D-Ala-D-Ala and oligopeptides 
(no D(L),D(L)-carboxypeptidase or D(L),D(L)-endopepti- 
dase activity in EcoVanX) but L,D-dipeptidase activity is 
possible. Although the catalytic efficiency for L-Ala-D-Ala 
is unimpressive and there is no known physiological source 
of L-Ala-D-Ala, L,D-meso-diaminopimelic acid (A2pm)- 
A,pm cross-links are engineered into E. coli peptidoglycan 
layers (10% of cross-links) as cells enter stationary phase 
[30] (Figure 7 and Sb). It remains to be seen whether free 
L,D-A2pm-A2pm dipeptides (Figure 7, compound c; not 
available for this study) might be substrates for EcoVanX 
operating in a salvage pathway. Another possible substrate 
could be the L-A2pm-D-A2pm dipeptide (Figure 7, com- 
pound b) reported to be released in the medium by expo- 
nentially growing E. co/i [31]. Indeed, this dipeptide was 
reported to be poorly taken up during the exponential 
growth phase [32], a stage at which the dipeptide permease 
and EcoVanX are shown here to be poorly induced as well. 
Although L-A2pm-D-Ala was shown to be partially cleaved 
before uptake [32], the sequential activity of the dipep- 
tide permease and EcoVanX could represent a salvage 
pathway for this pseudopeptide during stationary phase. 
An L-A2pm-D-Ala (L-Lys-D-Ala) dipeptidase enzyme has 
been characterized in sporulating cells of Bacdhs sphaeticus 
9602 [33]. Contrary to EcoVanX, this enzyme showed no 
activity on D-Ala-D-Ala. There is no known L,D-endopepti- 
dase that could cleave the peptidogycan linkage L-Ala- 
D-Glu, but cleavage of the linkage between D-Glu-L-A2pm 
has been described in organisms other than E. colz [34]. 
Although not explicitly detected, L-Ala-D-Glu and 
D-Glu-L-A2pm dipeptides are potential fragments of pepti- 
dogycan turnover (Figure 7, compounds a and f, respec- 
tively). An L-Ala-D-GluNH2 dipeptide did not show any 
activity with purified EcoVanX and because of the strict 
exclusion of L-amino acid at the carboxyl terminus of the 
dipeptide, the dipeptide D-Glu-L-A2pm is also unlikely to 
be an EcoVang substrate. 
A more likely scenario is that D-Ala-D-Ala is the physio- 
logical substrate for EcoVanX, in which case its regulation 
must be tightly controlled as there can be few circum- 
stances under which E. coli will hydrolyze substantial 
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Figure 7 
Possible dipeptides from endopeptidase, 
muramidase and carboxypeptidase action on 
E. co/i pepfidoglycan. D-Ala-D-A,pm is the 
prevailing cross-link 1371. During stationary 
phase, A,pm-A,pm cross-linkages increase 
up to 10% of total cross-linkages [311. 
Cleavage between L-Ala-o-Glu has not been 
discovered (9) nor between A,pm-A,pm (IO). 
The formation of the dipeptide o-Ala-o-A,pm 
requires the action of a putative L-Aspm-o-Ala 
endopeptidase (11). In red are dipeptide 
products identified to be released by E. co/i 
[32,38]. The numbers indicate the cleavage 
point by a specific murein hydrolase: 1, 
N-acetylglucosaminidase; 2, lytic 
transglycolase; 3, IV-acetylmuramyl-L-alanine 
amidase; 4, y-oglutamyl+-diaminopimelic acid 
endopeptidase; 5, L,o-carboxypeptidase; 6, 
o,o-carboxypeptidase; 7, o,oendopeptidase; 
8, L,o-dipeptidylcarboxypeptidase. A,pm, 
diaminopimelic acid; GlcNAc, N-acetyl- 
glucosamine; MurNAc, /V-acetylmuramic acid. 
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amounts of its D-Ala-D-Ala cytoplasmic pool and put 
peptidoglycan synthesis at risk (we suggest below that 
the source of D-Ala-D-Ala for EcovanX action might in 
fact be periplasmic). One instance when increased cata- 
bolic capacity is warranted is when supplies of essential 
nutrient(s) are exhausted and the cells make the transi- 
tion to stationary phase and assume a protective mode 
against various stresses. One of the attributes of stationary 
phase is a switchover to maintenance metabolism. Among 
the many genes induced by the @ subunit (one of the 
global regulators in the stationary-phase response [16]) 
are some enzymes, including those which make osmopro- 
tectants, scavengers and DNA repair enzymes, but also 
some that break down glycogen, increase gluconeogene- 
sis, and convert pyruvate to acetate ([16] and references 
cited therein). This last transformation is carried out by 
pyruvate oxidase (POX) and releases electrons into the 
respiratory chain. 
The demonstration here that EcoVanX is induced by an 
RpoS-dependent promoter raises the possibility that this 
is a maintenance metabolic response and focuses on the 
two D-Ala products as shown in Figure 8a, as energy 
sources. Akin to the POX reaction, the membranous 
D-ADH releases two electrons into the respiratory chain 
for each D-Ala it oxidizes to pyruvate. The tandem action 
of D-ADH and POX converts each D-Ala to acetate, NH,, 
CO, and four electrons that generate four equivalents of 
ATP to power a starving cell. 
This hypothesis raises the broader issue of whether 
periplasmic D-Ala-D-Ala is indeed released from the pep- 
tidoglycan and can be recycled back into the cytoplasm, 
especially in stationary phase. The operon organization 
and the demonstration of coexpression of ecooatzX and 
dipeptide permease genes increases this likelihood. The 
results presented here, that coexpression of these genes 
allows growth on exogenous D-Ala-D-Ala is consistent 
with such retrieval of D-Ala-D-Ala. We note that it 
remains to be shown that ORFs ABCDE (Figure 4) are 
indeed D,D-specific, but there has long been evidence 
that D-Ala-D-Ala and a few selected analogs can be taken 
up by E. cob [35]. 
In a broad context, Figure 8a shows both D-Ala and also 
D-Ala-D-Ala as points of metabolic intersection of ana- 
bolic and catabolic routes in E. co/i. In recent years much 
attention has been duly given to the discovery that about 
50% of the periplasmic peptidoglycan (about 3.5 million 
molecules/cell) is turned over in each E. coli generation, 
GlcNAc-anhydroMurNAc tripeptide and free L-Ala- 
D-Glu-L-Azpm tripeptide are the cell-wall fragments 
that are transported back into the cytoplasm by trans- 
membrane AmpG and MppA and hydrolyzed by the 
amidase AmpD. The L-Ala-D-Glu-L-Azpm tripeptide is 
then recycled [36]. No attention has been given to the 
fate of the D-Ala released from peptidoglycan tetrapeptide 
termini or the D-Ala-D-Ala from the uncross-linked pep- 
tidogycan pentapeptide termini. Although it has been 
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Figure 8 
D-Ala and D-Ala-D-Ala as branch point 
metabolites in E. co/i. Proposed action of 
EcoVanX and the putative dipeptide 
permease. (a) Recycling of peptidoglycan 
turnover products. Peptidoglycan is 
degraded by several hydrolases (see 
Figure 7). The periplasmic GlcNAc-MurNAc- 
tripeptide product can be transported 
directly into the cytoplasm by AmpG and 
then converted by 
AmpD/Glucosaminidase(Gluase) into 
tripeptide (L-Ala-D-Glu-L-A,pm: black 
circles) and disaccharide (GlcNAc-MurNAc, 
gray ovals) or degraded by AmiA to the 
disaccharide and tripeptide units (see [37] 
for review). Periplasmic tripeptide is 
transported by a specific murein peptide 
permease (Mpp) [60] or by the oligopeptide 
permease (Opp) [37]. Tripeptide can be 
reused directly for the synthesis of 
peptidoglycan precursors for subsequent 
cell-wall biosynthesis. The fate of the 
periplasmic disaccharide is not known. D-Ala 
(red circle) monomer released from the 
transpeptidation reaction (D-Ala-D-A,pm) and 
the DD-(LD-) carboxypeptidase reaction is 
transported by the CycA system [61 I into the 
cytoplasm. During stationary phase, 
periplasmic D-Ala-D-Ala dipeptide might be 
transported by a novel dipeptide transport 
system into the cytoplasm where it could be 
processed by two different pathways: 
recyclization by MurF for cell-wall 
biosynthesis or degradation to its monomer 
by EcoVanX. As a possible route for 
production of energy during starvation, the D- 
Ala would be converted to acetate by the 
sequential action of D-amino acid 
dehydrogenase (D-ADH) and pyruvate 
oxidase (POX). D-Ala could also be 
converted back into D-Ala-D-Ala by the Ddl 
ligase or into L-Ala necessary for protein 
synthesis by a racemase (Alr) or into 
pyruvate/ammonia to be used as a 
carbon/nitrogen source. (b) Possible source 
of periplasmic D-Ala-D-Ala. During stationary 
phase, A,pm-A,pm cross-linkages increase 
up to 10% of total cross-linkages [31]. It is 
predicted that this reaction would release a 
single monomer of D-Ala [37] or a D-Ala- 
D-Ala dipeptide moiety. It has been shown 
that D-Ala-D-Ala is released by an 
L,D-dipeptidylcarboxypeptidase from 
peptidogycan precursors [38]. The latter 
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enzyme could also be the A,pm-A,pm diaminopimelic acid; GlcNAc, 
transpeptidase, the gene and gene product 
of which have yet to be identified. A,pm, 
N-acetylglucosamine; MurNAc, 
N-acetylmuramic acid. 
assumed the A2pm-A2pm cross-links that form in station- stationary phase provided that the cells also turn on the 
ary phase arise from tetrapeptide chains that release genes for retrieval and hydrolysis of the D,D-dipeptide; 
D-Ala [36], in fact the enzyme has not been characterized analogous to burning the walls of the house to generate 
and it is possible that the substrates are pentapeptide heat. The L,D-dipeptidylcarboxypeptidase cleaving the 
chains, releasing D-Ala-D-Ala in the A2pm-A2pm cross- L-A2pm-D-Ala-D-Ala termini at the L-Dap-D-Ala 
links form (Figure 8b). Such cross-links would then lib- peptide bond, previously described in E. co/i [37], could 
erate a potential energy source for the starving cell in in fact be the A2pm-Azpm transpeptidase (Figure 8b), 
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perhaps also turned on in an RpoS-dependent manner. For 
each D-Ala-D-Ala thus retrieved from the peptidoglycan 
termini, eight ATPs could be produced by the tandem 
action of POX and D-ADH suggested in Figure 8a. This 
might be the reason for switching from L-A,pm-D-Ala to 
A2pm-A2pm cross-links in stationary phase. 
Less is known about the putative physiological function of 
SynVanX. It clearly exhibits zinc-mediated dipeptidase 
activity but is also atypical as it can hydrolyze both L-Ala- 
D-Ala and D-Ala-D-Ala with similar efficiency. No dipep- 
tide permease genes are clustered close to the synvanX 
gene. Given the insensitivity of Synechoqw‘is to glycopeptide 
antibiotics by reason of antibiotic exclusion, it is unlikely 
that SynVanX plays any immunity-conferring function and 
more likely that it plays a scavenging role for L,D-and 
D,D-dipeptide products of cell-wall degradation pathways. 
As additional bacterial genomes are sequenced, more 
VanX proteins homologs are likely to be discovered. 
Indeed, in the gram-positive pathogen Mycobacterizlm her- 
czllosis there is a VanX homolog, this time with an apparent 
signal sequence and membrane lipoprotein attachment site 
(ORF-MTV043.31, accession 2916897, [38]) suggesting 
that MtuVanX might reside in the membrane. 
Significance 
The metallodipeptidase VanX (EntVanX) plays an essen- 
tial role in life-threatening, pathogenic vancomycin-resis- 
tant enterococci (VRE) by hydrolyzing the D-Ala-D-Ma 
dipeptide but not the D-Ala-D-lactate depsipeptide during 
rerouting of cell-wall intermediates. There is interest in 
the likely origin of the transposon-encoded vanXin VRE 
and its distribution in other bacteria, both gram-positive 
and gram-negative. We report on the detection, overpro- 
duction and kinetic characterization of three bacterial 
VanX homologs from the glycopeptide-antibiotic producer 
Streptomyces toyocaensis (StoVanX), from Eschen’chia 
coil (EcoVanX) and from the cyanobacterium Syne- 
chocystis sp. strain PCC6803 (SynVanXI. 
The StoVanX homolog (64% similarity with EntVanX), 
whose gene is found clustered within a vanHAXoperon, 
exhibits similar kinetic parameters to EntVanX, consis- 
tent with an antibiotic immunity function in the S. toy- 
ocaensis producer and indicative of a possible common 
evolutionary origin. EcoVanX and SynVanX show much 
lower sequence homology to EntVanX (27% and 16% 
respectively), are found in gram-negative bacteria that 
have no comparable susceptibility to vancomycin or need 
for defense against this antibiotic and show 200-fold ele- 
vation in KM values for D-Ala-D-Ala hydrolysis com- 
pared to EntVanX, which suggests a probable role for 
these enzymes in cell-wall turnover. 
Directly downstream of the ecovanX gene is a putative 
dipeptide permease gene cluster, the products of which 
show capacity to import D-Ma-D-Ala into the cell. These 
genes form an operon under the control of the stationary 
phase transcription factor RpoS. The consecutive action 
of EcoVanX and the membranous D-amino acid dehydro- 
genase and pyruvate oxidase would allow the cell to utilize 
D-Ala-D-Ma as an energy source for cefl survival under 
starvation conditions. Periplasmic D-Ala-D-Ala could 
be provided by the diaminopimelic acid (Azpm)-A2pm 
cross-link action, which substantially increases during sta- 
tionary phase. This potential energy source could be the 
reason for switching from L-A2pm-D-Ala to A2pm- 
Azpm cross-links. 
Materials and methods 
Materials 
Bacteriological media were obtained from Difco Laboratories. Compe- 
tent f. co/i strain BL21 (DE3) was purchased from Novagen. Compe- 
tent E. co/i strain DH5cc and DNase I were purchased from GibcoBRL. 
Restriction endonucleases, T4 DNA ligase, calf intestinal alkaline phos- 
phatase, and amylose resin were obtained from New England Biolabs. 
ffu DNA polymerase was purchased from Stratagene. Isopropyl-l -thio- 
P-D-galactopyranoside (IPTG), L-Ala-D-Ala, D-Ala-L-Ala, L-Ala-D-Gln, 
L-Ala-P-D-Glu-D-Lys-D-Ala-D-Ala and D-Ala-D-Ala-OMe were pur- 
chased from Bachem Biosciences. Kanamycin, ampicillin, chloram- 
phenicol, D-Ala-D-Ala, L-Ala-L-Ala, N-acetyl-D-Ala-D-Ala, D-Ala- 
D-Ala-D-Ala and L-Ala-L-Ala-L-Ala were purchased froni Sigma. 
D-Ala-D-lactate has been synthesized previously in this laboratory [l 21. 
Chelex-100 resin and low molecular weight markers for polyact-ylamide 
gel electrophoresis (PAGE) were obtained from Bio-Rad. Genomic 
DNA from Synechocysfis sp. strain PCC6803 was the kind gift of 
Dr. Louis Sherman (Purdue University). f. co/i strains and plasmids 
used in this work are presented in Table 3. 
Recombinant DNA methods 
Recombinant DNA techniques were performed as described else- 
where [391. Preparation of plasmid DNA, gel-purification of DNA frag- 
ments, purification of PCR-amplified DNA fragments [40,41], and 
preparation of total RNA were performed using QlAprep@ spin 
plasmid miniprep, QIAEX@ II gel extraction, QIAquickTM PCR, and 
RNeasy@ purification kits, respectively (QIAGEN). PCR reactions 
were carried out as described previously [42] using Pfu DNA poly- 
merase. Variations in the general PCR conditions are noted in the text. 
Splicing by overlap extension (SOE) reactions [43] were carried out 
similarly using approximately an equimolar ratio (total amount -50 ng) 
of each gel-purified PCR-amplified DNA fragments to be joined as 
template. The fidelity of the SOE- or PCR-amplified DNA fragments 
was verified by nucleotide sequencing of the respective cloned frag- 
ments. Oligonucleotide primers were obtained from Integrated DNA 
Technologies, and DNA sequencing was performed on double- 
stranded DNA by the Molecular Biology Core Facility of the Dana 
Farber Cancer Institute (Boston, MA). 
Construction of expression vectors for MBP-VanX fusion 
proteins 
The expression vector for MBP-VanX (MBP-EntVanX& fusion protein 
(plADLI4 [91) was used to construct vectors for the expression of the 
genes encoding StoVanX, EcoVanX and SynVanX. The stovanX [l 11 and 
synvanX (ORF-slrl679, accession 1653448 [44]) genes were PCR- 
amplified from pBlutoyVnX5.4 and Synechocystis genomic DNA using 
the primer pairs 2033/l 034, and 2045/l 037, respectively (Table 4). For 
amplification of the ecovanxgene (ORF-fl93, accession 1787763 [45]), 
a single colony of f. co/i strain BW24320 (Table 3) was resuspended in 
40 ~1 of 10 mM Tris (pH 8.3), 50 mM KCI, 2.5 mM MgCI,, 20 mM DTT 
and 1.8 PM SDS and incubated for 30 min at 37%. Supernatant from 
the lysed cells (5 ~1) was used as the template for PCR using the primer 
pair 2032/l 033 (Table 4). PCR products were digested with Ndel and 
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Table 3 
Escherkhia co/i strains and plasmids used in this work. 
Construction Description 
Strains* 
BL21 (DE3) 
BW21480 
BW22653 
BW24320 
BW25113 
BW25141 
DH5a 
IADL307 
IADL310 
IADL313 
IADL318 
IADL319 
IADL321 
NM522 
SMl Oh pir 
SPNM-1 
SPI 4-2 
XL1 -Blue 
F-, ompT, hsdS,, (re-,ms-), gal, dcm, X(DE3) 
Ia& rrnBTs14 AlacZ,,, p r oS(Am) 
/a& rrnBr, 4 AlacZ,, 6 
/a& rrnBT,4 A/acZ,,,,,,s p A hoBR580 AcreABCD154 AaraBADAHz7 ArhaBAD,,,, 
/a& rrng,, AlacZ,,,,,,, h&R51 4 AaraBAD,,,, ArhaBADLD,, 
/a& rrnBr, 4 AlacZ,,,, AphoBR580 hsdR514 AaraBADAHx3 ArhaBADLD,, 
uidA (An/llul)::pir+ rpoS(Am) endA,,,, gallJ95 recA 7 
F-, 48OdlacZAM75, A(/acZYA-argF)lJ769, deoR, recA1, endA1, hsdR77(rK-, rnK+)$ 
phoA, supE44, h-, thi-1, gyrA96, relA 1 
Like BW25113 except aff/l::plADL93 (P,,,-ecovan)i7 
Like BW22653 except atfil::plADL96 (Pe,,,,x-lac~ 
Like BW21480 except att/l::plADL96 (P,,,,&acZ) 
Like BW25113 except atfil::plADLlOl (P,e,-enfvanX,) 
Like BW25113 except att,4’K022::plADLlOO (P,a,-dipeptide permease) 
Like IADL307 except affHKO22::plADLlOO (P,,,-dipepfide permease) 
supE thi-l A(/ac-proAB) A(mcrB-hsdSM)S (rK-, mK-) [F’ proAB laclqZAM751 
fhi fhr leu tonA lacy supE recA::RP4-2Tc::Mu kan Lpir 
Like NM522 except rifampicin 
Like SPNM-1 except ecovanX::caf 
recA 1 endA 1 gyrA96 thi-1 hsdR17 supE44 relA 1 lac [F’ proAB lacPZAMl51 Tn IO (Tetr)l 
Plasmids 
pACYCl84 
pAH125 
pBlutoyVnX5.4 
pDEB2 
plADLl4 
plADL55 
plADL58 
plADL60 
plADL70 
plADL72 
plADL73 
plADL74 
plADL75 
plADL76 
plADL93 
plADL96 
plADLlO0 
plADLlO1 
PINT-ts 
pKNGlO1 
pKXG5 
pSPORT1 
pUCl8/19 
pUEX 
pUEXC 
orip,5A, cat, fet 
/acZ transcriptional fusion vector, attP,, oriRREKr kan 
5’-end dd/M, sfovanX genes in pBluescript, oriMe,, b/a 
P,a,-RpoS producing plasmid, oriMe,, b/a 
P,-MBP-EntVanXA overproducing plasmid, ori,,,,e,, kan 
P,-MBP-EcoVanX overproducing plasmid, or&,, kan 
P,-MBP-SynVanX overproducing plasmid, oriMB,, kan 
P,-MBP-StoVanX overproducing plasmid, or&,e,, kan 
ecovanX gene, attP,, oriRReKy kan 
orfABCD and 5’-end orfFdipeptide permease genes in pUCl9 
3’-end orfFdipeptide permease gene in pUCl9 
OrfABCDFdipeptide permease genes in pUCl9 
P ,h,,-genelV, attPHKop2, oriR,,Ky cat 
P ,,,,B-dipeptide permease, attPHKo22, oriRRsKr, cat 
P,a,-EcoVanX producing plasmid, attP*, oriR,,,?, kan 
P eco,,anx-LacZ fusion, attP,, oriRRsKr kan 
P,a,-dipeptide permease, attPHKOPS, oriRRsKr cat 
P,a,-EntVanX,, atfP,, oriR,,Ky kan 
P,-h integrase producing plasmid, ori+C,O,.tsr b/a 
sacBR, mob,,,, oriR,,,, strA, 
1.5 kb-ecovanX::cat-1.2 kb, sacBR, mob,,,, oriR,,,, sfrAe 
Pia, oriMal, b/a 
or&,e,, bla 
1.5 kb-ecovanx-1.2 kb, or&e,, bla 
1.5 kb-ecovanX::cat-1.2 kb, oriMe,, bla 
Reference/Source 
Novagen 
[541 
t 
* 
* 
* 
Stratagene 
This study 
This study 
This study 
This study 
This study 
This study 
Stratagene 
[551 
This study 
This study 
Stratagene 
NEB# 
11 
[ill 
[561 
[91 
This study 
This study 
This study 
Y 
This study 
This study 
This study 
Y 
This study 
This study 
This study 
This study 
This study 
[571 
WI 
This study 
Gibco BRL 
NEB 
This study 
This study 
*All E. co/i strains listed are derived from strain K-l 2, except for 
BL21 (DE3) which is derived from strain B. +Jiang, W., Haldimann, A. & 
Wanner, B.L., unpublished strain. *Haldimann, A. &Wanner, B.L., 
unpublished strains and vector. SPlasmid with oriR,,K, required E. co/i 
strain harboring the pir gene for replication; orfABCDF, see Figure 4. 
#New England BioLabs. ?S.K. Kim, A. Haldimann and B.L. Wanner, 
unpublished vectors. ‘I.A.D.L. & C.T.W., unpublished vectors. 
HindIll, and the resulting vanX homolog-containing DNA fragments were 
gel-purified and cloned into plADLl4. The resulting plasmids plADL55, 
plADL58 and plADL60 encode MBP fusions with EcoVanX, SynVanX 
and StoVanX, respectively. E. co/i strains DH5CY. and BL21 (DE3) were 
used as cloning and expression hosts. 
Overproduction and purification of MBP-VanX homologs 
Overproduction and purification of the MPB-VanX homologs were per- 
formed as described previously 191 with the following two modifications: 
buffer A contained 300 mM NaCI, and ZnSO, (I 0 mM stock solution) 
was added to the purified protein to a final concentration of 200 FM 
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Table 4 
Oliaonucleotide primers for PCR. 
Comment Code 
P,-StoVanX 2045 
P,-StoVanX 1037 
P n-EcoVanX 2032 
P,-EcoVanX 1033 
P,-SynVanX 2033 
P,-SynVanX 1034 
P eCOWnX 2081 
P 
XOVXlX 
1039 
Dipeptide permease, 5’-end 2060 
Dipeptide permease, 5’.end 1049 
Dipeptide permease, 3’-end 2063 
Dipeptide permease, 3’-end 1052 
Dipeptide permease, Ndel- 1051 
Dipeptide permease, Ncfel- 2065 
P,a,-EcoVanX 2044 
P,a,-EcoVanX 1053 
P kc 1071 
P kc 2077 
affh 1023 
affh 2023 
attHK022 1024 
attHK022 2024 
aft-plasmid 1027 
aft-plasmid 2027 
uPeco”a”x 4001 
down hX%allX 3001 
cat 4002 
cat 3002 
RT-P’%,v,nx-o, 4003 
RT-PCRcovanx-o, 3003 
RT-P’TE-,~+F 4004 
RT-+'CR,,B-,,F 3004 
5’-3’ Nucleotide sequence 
CGCAAGCTTCTACATGATGGGGAAATCGAAGT 
AGGATCCCAfATGAAGCCGACGGAGTCCATGA 
CAGGAACCGCATATGTCGGATACCACCGAACTGG 
CAGTTTCAAGCTTAACTGACGTGCTGTGTGCC 
CAGGAACCGCATATGTCCTTTGATACCCCGCTCAAAC 
CAG7lTCAAGCTTCATTCAACCCGGCCGTAGTAGG 
GGCCTGCAGATGAGCAGCGTGTTACCGCTG 
CGGAATTCGTATAAGACAAAAATTGCTGCGCTTCC 
CAGGAATTCCATATGAAGAGATCGATATCGTTTC 
CCGTCTAGAGCAGACGCATAATCAG 
CACGAATCAACAATGTGTCCTTGC 
CGTTCTAGACGCGTCTACAGCGCCCGCCAGC 
GATCGCTCATGTGACGTATCACCGAG 
CTCGGTGATACGTCACATGAGCGAT 
AGTTCTAGAGGATCCTTAACTGACGTGCTGTGTG 
GGACTT-TCTGCGCGTCTGATTAAGC 
CTCCTCTACATATGTATATCTCCTGTGTGAAATTGTTATCCGCTCAC 
GGGCATGCAI-TAATGCAGCTGGCACGACAGG 
GGCATCACGGCAATATAC 
TCTGGTCTGGTAGCAATG 
GGAATCAATGCCTGAGTG 
GGCATCAACAGCACATTC 
ACGAGTATCGAGATGGCA 
ACTTAACGGCTGACATGG 
GTCACGGTCGACACCGGTCTGCCAAATCGCAA 
GTCACGGGATCCCAGTTGCCAATCGCAATGTCGTA 
GGTCACGCTCAGCTATAAGAGTTATCGAGATTTTCAGGAGCTA 
TAACGATGCTGAGCAGGGCACCAATAACTGCCTT 
GTCGGATACCACCGAACTGGTTGATTT 
GCGCTTTGCTGTTATTCAGATACAGATAGGTAA 
TTGCCGTCGTGGTTTCATTTGCTTA 
AAGCGAAGAGAGCGGGTCCTGAA 
Mismatches are bold and italicized. 
and incubated for 1 hour on ice prior to dialysis. The yield of pure MBP- 
VanX homolog proteins obtained from a 1 I culture of induced f. co/i 
BL21 (DE3) cells was -40 mg. 
Protein quantitation and SDS-PAGE 
Concentrations of pure protein were determined by using UV-Vis 
spectroscopy (&,,a= 118,720 M-‘cm-’ [MBP-EntVanXl, &,,a= 
115,740 M-‘cm-1 [MBP-StoVanX], Es,= 93,280 M-‘cm-l (MBP- 
EcoVanX) and E2s0= 118,720 M-‘cm-’ [MBP-SynVanXj). The extinction 
coefficients were calculated using a modification of the Edelhoch 
method [46,47]. Proteins were separated by SDS-PAGE using a dis- 
continuous Trislglycine buffer [481 with 10% acrylamide resolving gels 
and 5% acrylamide stacking gels containing 0.1% SDS. 
Assays for enzyme activity and ICP-metal analysis 
Peptidase activity was measured in 50 mM Tris (pH 8.0) at 37°C 
according to published procedures [12] using the modified cadmium- 
ninhydrin assay method, which detects the concentration of free D-Ala 
[49]. Protein samples were prepared for metal analysis as described 
earlier [9] except that dialysis was performed with three changes of 
buffer. Protein samples were analyzed for metal content at the Univer- 
sity of Georgia Chemical Analysis Laboratory (Athens, GA). The detec- 
tion limit for zinc was determined to be ~1 ppb. 
Construction of E. coli strains harboring promoter fusion 
(ecovanx) with IacZ 
A 282 bp DNA segment upstream of the Shine-Delgarno (SD) 
sequence of the ecovad gene (Figure 4) was fused with the /acZ gene. 
This DNA fragment included a putative transcriptional terminator and the 
last 9 coding amino acids of a hypothetical gene (ORF-f807, accession 
1787765 [45]). The 282 bp DNA fragment was PCR-amplified from a 
single colony of E. co/i strain BW24320 (Table 4) as described above 
using the primer pair 2081 /lo39 (Table 4) with an annealing tempera- 
ture (T,,) of 60°C. The PCR product was digested with EcoRl and Psfl, 
gel-purified and cloned into pAH125, to create plADL96. The E. co/i 
strain BW25141 (Table 3) contains a chromosomal copy of the pir gene 
(TC protein) required for replication (acting in trans) of this oriR,,kfbased 
plasmid [50] and was used as the cloning host. The plADL96 plasmid 
was integrated into afd in E co/i strains BW21480 and BW22653 
(Table 3) as described earlier [50]. Single integrations were verified by 
PCR using the primers 1023/2023/l 027/2027 with a T,, of 6O’C. The 
resulting E. co/i strains, IADL310 and IADL313, contain a single chromo- 
somal copy of the promoter fusion construct at the affil site (Table 3). 
Assay of the promoter fusion with IacZ 
A single colony of E. co/i strain IADL310 or lADL313 was used to inoc- 
ulate 5 ml of LB media containing 5 ug/ml of kanamycin and grown 
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overnight at 37%. The cultures were diluted I O-fold in LB media and 
growth was continued for 30 min at 37%. This step was repeated 
twice after which the cultures were diluted IO-fold into 50 ml of LB 
media and growth was followed at 37°C. Samples were taken at differ- 
ent times over 24 h for determination of the /3-galactosidase activity 
and for cell density measurements at 600 nm. P-galactosidase activity 
was assayed with orfho-nitrophenyl-galactopyranoside in quantitative 
liquid culture assays as described by Miller [51]. The assay was per 
formed iii triplicate from separate colonies, 
Analysis of the transcript for ecovanX and the dipeptide 
permease cluster genes 
E. co//strain NM522 was grown in 3 ml LB at 37°C to an CID,,, of 0.78 
(exponentiai phase) and 2.32 (stationary phase) and used for preparation 
of total RNA. The preparations of RNA were further treated by DNase I 
and amplified by RT-PCR using the Takara BcaBest RNA PCR kit 
(Takara Shuzo Co.) as described by the manufacturer and primer pairs 
4003/3003 and 4004/3004 (T, of 62%). ldentitjr of ,the PZR products 
was confirmed by restriction mapping. 
Construction of E. co/i strains expressing ecovanX, entvanx, 
and a putative dipeptide permease system ciuster genes 
rhe ecavanX gene was PCR-amplified from plADL55 using the primer 
pair 1053/2044 (Table 4). The PCR product was digested with Ndei 
and BarnHI, gel-purified and cloned into pAH135, to create plADL70. 
Pi,, was PCR-ampiified from @PORT1 using the primer pair 10711 
2077 (Table 4). The PCR product was digested with A!del and Sphl, gel- 
purified and cloned into pIAD!-70, to create piADL.93. The en&a&‘,, 
gene was cloned into piADL93 at the Ndel and Xrnal sites from plADLl4 
to create plADLlO1. Plasmids plADL93 and plADLi 01 were then inte 
grated into attk of E. coti strain BW25i 13 (Table 3) as described earlier 
[50] to create straille iADL307 and iADL318, respectively. Single inte- 
gration was verified by PCR using the primers 4 023/2023/2027/i 027 
(T,, of 60°C). f. colistrain BW25141 was used as the cloning host. 
The entire putative dipeptide permease cluster of genes found just 13 bp 
downstream of the ecovanX gene (Figure 4) was cloned froin E. co/i 
strain BW24325 by colony PCR (see above). The 5’-end sequence was 
PCR-amplified from a singls colony using the primer pair 2060/1049 
(Table 4) with a IO min extension lime (t,,) and a T,, of 48%, producing 
a 3660 bp DNA fragment. The PCR product was digested with iv&l and 
Xhal, gel-purified and cloned into pUGl9, to create plADL.72. At the 3’. 
end sequence, an internal Ndel restriction site was removed by silent 
mutagenesis using the SOE method. For the first round of PCR, the 
sequence upstream and downstream of the Ndei restriction site were 
separately amplified using the primer pairs 2063/l 051 and 2065/i 052 
(Table 4), respectively (t,, of 8 min, T,, of 48%). The resulting DNA frag- 
ments (4547 bp and 333 bp, respectively) were gel-purified and sub- 
jected to a second round of PCR using the primer pair 2063/l 052 with 
the above conditions. Tine SOE-purified DNA fragment (1854 bp) was 
digested with EcoRl and Xbal and cioned into pUCl9, to create 
pfADL73. The 5’-end sequence of the cluster was then subcloned into 
piADL73 at the Sacll and Ndel sites to create plADL74. The entire 
dipeptide permease genes cluster was subcloned into plADi75 at the 
Rsdel and M/ul sites, to create plADL76. Plasmid plADL75 (I.A.D.L. and 
C.T.W. unpublished vector) is a pSK49 based plasmid [50] possessing 
rhe Prhaev the cat gene, the aBPHKo2? site for integration into the chromo- 
some into attHK022 and or/R,,,+, (A. Haldimann and B.L. Wanner, 
unpublished observations). P,ac was subcloned from plADL93 into 
plADL7.6 at the iVdellSpipl;i sites to create pIADLlO0. Plasmid plADLlO0 
was integrated into attHKOZ.2 of E. co/i strains BW25113 and IADL307 
as described earlier [50] to create strains lADl.319 and IADL321, 
respectively. Single integration ‘was confirmed by PCR using the primers 
1024i2@24llO27/2027 (T, of 60%). 
inseriionai inaciiv&‘on of the chromosomai ecovanx gene 
Inactivaticn of ecovanX gene was accomplished by insertion of the caf 
Qene into the Spul 1021 site of ecovanX The chromosomal region har- 
boring the ecovan)i’gene, pius 1.5 kb upstream and 1.2 kb downstream 
sequences, was PCR-amplified from E. co/i strain XL1 Blue, using the 
primer pair 4001/3001 (Table 4). The PCR product was cloned into 
pUC18 at the Sail and BamHI sites to create pUEX. Tie cat gene was 
PCR-amplified from pACYC184 using the prilner pair 4002/3002 
(Table 4) and cloned at the @till 021 site of ecovanX in pUEX to create 
pUEXC. The .%/I-BarnHi region of pUEXC was then subcloned into the 
suicide vector pKNG104 to create pKXCd using E. co/i strain SMI 0 h 
pir (permissive host strain for pKNG401) as the host (donor strain). 
E. co/i strain NM622 was selected for resistance to 100 pglml 
rifampicin to produce SPNM-I (acceptor strain). Recombination was 
performed using conjugation by the following procedure: SMlO h 
pir/pKXC-5 (LB, 40 pg/ml chloramphenicol, 50 ygiml streptomycin) and 
SPNM-1 (LB, 100 ILg/ml rifampicin) cells were separately grown 
overniQht at 37% The overnight cultures were then diluted 1 :I 0 in 1 ml 
LB to give a final CID,,, of c.a. 0.5, centrifuged, and resuspended in 
600 ~1 antibiotic-free LB. A 200 ~1 sample from each culture was mixed, 
centrifuged, the pellets resuspended in 10 ~1 LB and spotted onto a 
prewarmed LB plate which was then incubated at 37°C for 5 h to allow 
conjugation (individual cultures were used as controls). Spotted bacte- 
ria were scraped and resuspended in 600 ~1 LB, plated on LB plates 
(100 lkglrnl rifampicin, 25 pg/ml chloramphenicol, and 10 pg/ml strepto- 
mycin) and incubated at 37°C overnight. Colonies were grown in 3 ml 
LB (same antibiotics as the plates) at 37°C for 6 h and streaked on LB 
agar containing 25 Fg/ml chloramphenicol and 5% sucrose to force a 
second crossover, removing the nonhomologous portion of the inte- 
grated pKXC-5 plasmid from the chromosome. Colonies from this 
experiment were replica plated with and without streptomycin to confirm 
loss of plasmid DNA. Recombinants were analyzed by Southern blot 
and PCR to confirm insertion of cat. 
Homoloyy modeling of EcoVanX using EntVanXA as the 
template 
Homology modeling was performed using the crystal structure of Ent- 
Van& [IO], a sequence alignment of the EntVanX, and EcoVanX 
sequences generated using Clustal W 1521, and the Modeller 
program [53]. 
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